![Sudden Price Drop Makes This High-Yield Stock a Good Buy for My Monthly Dividend Reinvestment: AbbVie (ABBV) - Dividends and Income Sudden Price Drop Makes This High-Yield Stock a Good Buy for My Monthly Dividend Reinvestment: AbbVie (ABBV) - Dividends and Income](https://dividendsandincome.com/wp-content/uploads/2021/09/2.png)
Sudden Price Drop Makes This High-Yield Stock a Good Buy for My Monthly Dividend Reinvestment: AbbVie (ABBV) - Dividends and Income
![Sudden Price Drop Makes This High-Yield Stock a Good Buy for My Monthly Dividend Reinvestment: AbbVie (ABBV) - Dividends and Income Sudden Price Drop Makes This High-Yield Stock a Good Buy for My Monthly Dividend Reinvestment: AbbVie (ABBV) - Dividends and Income](https://i0.wp.com/dividendsandincome.com/wp-content/uploads/2021/09/2-1.png?resize=636%2C328&ssl=1)
Sudden Price Drop Makes This High-Yield Stock a Good Buy for My Monthly Dividend Reinvestment: AbbVie (ABBV) - Dividends and Income
![AbbVie's ex-U.S. Humira sales are on the precipice. But no need to panic, analysts say | Fierce Pharma AbbVie's ex-U.S. Humira sales are on the precipice. But no need to panic, analysts say | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/2016-12/AbbVieHQE_0045.jpg?VersionId=LrEOjwaP0FflIiTPRsahAoQc1myFNMr_)